Table 3 Number of patients fitting two categories
From: Response to treatment of myasthenia gravis according to clinical subtype
| Â | Number of patients | Final assignment |
|---|---|---|
Ocular MG and thymoma-associated MG | 32 (2.9%) | Ocular MG |
Ocular MG and AChR-Ab-negative MG | 56 (5.1%) | Ocular MG |
Ocular MG and MG with thymic hyperplasia | 8 (0.7%) | Ocular MG |
MG with thymic hyperplasia and AChR-Ab-negative MG | 14 (1.3%) | THMG |
Thymoma-associated MG and AChR-Ab-negative MG | 1 (0.09%) | TAMG |